Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ST6GAL1 | P15907 | 3/20 | 0.38 |
| ▸ | ST3GAL1 | Q11201 | 2/20 | 0.38 |
| ▸ | ST3GAL3 | Q11203 | 2/20 | 0.38 |
| ▸ | FUT6 | P51993 | 1/20 | 0.33 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.33 |
| ▸ | CETP | P11597 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8133550 | 1.00 | ST6GAL1 (0.38) | ST6GAL1ST3GAL1ST3GAL3FUT6FUT5 | |
| SCHEMBL8147293 | 0.87 | ST6GAL1 (0.41) | ST6GAL1ST3GAL1ST3GAL3FUT6FUT5 | |
| SCHEMBL8142047 | 0.87 | ST6GAL1 (0.41) | ST6GAL1ST3GAL1ST3GAL3FUT6FUT5 | |
| SCHEMBL8147295 | 0.87 | ST6GAL1 (0.41) | ST6GAL1ST3GAL1ST3GAL3FUT6FUT5 | |
| SCHEMBL8142046 | 0.87 | ST6GAL1 (0.41) | ST6GAL1ST3GAL1ST3GAL3FUT6FUT5 | |
| SCHEMBL8133289 | 0.86 | ST6GAL1 (0.37) | ST6GAL1ST3GAL1ST3GAL3FUT6FUT5 | |
| SCHEMBL8149229 | 0.85 | ST6GAL1 (0.35) | ST6GAL1ST3GAL1ST3GAL3CETP | |
| SCHEMBL8149233 | 0.85 | ST6GAL1 (0.35) | ST6GAL1ST3GAL1ST3GAL3CETP | |
| SCHEMBL8143225 | 0.83 | ST6GAL1 (0.35) | ST6GAL1ST3GAL1ST3GAL3FUT6FUT5 | |
| SCHEMBL8143232 | 0.83 | ST6GAL1 (0.35) | ST6GAL1ST3GAL1ST3GAL3FUT6FUT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6143732-A | USED AS ANTIVIRAL AGENT AGAINST INFLUENZA VIRUS | SHIONOGI & CO., LTD. (JP) | 2000-11-07 | — | — | US | disclosed |